We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Key Psychiatric Drug Target Comes Into Focus

News   Oct 20, 2017 | Original Story by Nicholas Weiler for the University of California San Francisco.

 
Key Psychiatric Drug Target Comes Into Focus

Researchers have determined the crystal structure of a specific dopamine receptor called D4 at an incredibly high resolution. Credit: University of California San Francisco.

 
 
 

RELATED ARTICLES

What Makes Good Brain Proteins Turn Bad?

News

The protein FUS is implicated in two neurodegenerative diseases: amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Using a newly developed fruit fly model, researchers have zoomed in on the protein structure of FUS to gain more insight into how it causes neuronal toxicity and disease.

READ MORE

Kidney Cancer Driver Could Lead to New Treatment Strategy

News

Scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change can lead to an overabundance of blood vessels, which help feed nutrients to the tumors. Their latest finding shows a potential new cancer-driving pathway.

READ MORE

Targeting Headaches and Tumors with Nano-Submarines

News

Scientists have developed a new method to enable miniature drug-filled nanocarriers to dock on to immune cells, which in turn attack tumors. In the future, this may lead to targeted treatment that can largely eliminate damage to healthy tissue.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE